- Report
- May 2026
- 218 Pages
Japan
From €4374EUR$4,850USD£3,751GBP
- Report
- May 2026
- 221 Pages
Netherlands
From €4374EUR$4,850USD£3,751GBP
- Report
- May 2026
- 223 Pages
Saudi Arabia
From €4374EUR$4,850USD£3,751GBP
- Report
- May 2026
- 224 Pages
South Africa
From €4374EUR$4,850USD£3,751GBP
- Report
- May 2026
- 226 Pages
Spain
From €4374EUR$4,850USD£3,751GBP
- Report
- May 2026
- 227 Pages
Thailand
From €4374EUR$4,850USD£3,751GBP
- Report
- May 2026
- 228 Pages
Turkey
From €4374EUR$4,850USD£3,751GBP
- Report
- May 2026
- 229 Pages
United Kingdom
From €4374EUR$4,850USD£3,751GBP
- Report
- May 2026
- 214 Pages
Germany
From €4374EUR$4,850USD£3,751GBP
- Report
- May 2026
- 215 Pages
India
From €4374EUR$4,850USD£3,751GBP
- Report
- May 2026
- 219 Pages
Malaysia
From €4374EUR$4,850USD£3,751GBP
- Report
- May 2026
- 220 Pages
Mexico
From €4374EUR$4,850USD£3,751GBP
- Report
- May 2026
- 222 Pages
China
From €4374EUR$4,850USD£3,751GBP
- Report
- April 2026
- 150 Pages
Indonesia
From €4374EUR$4,850USD£3,751GBP
- Report
- March 2026
- 150 Pages
India
From €4374EUR$4,850USD£3,751GBP
- Report
- March 2026
- 150 Pages
Canada
From €4374EUR$4,850USD£3,751GBP
- Report
- March 2026
- 150 Pages
China
From €4374EUR$4,850USD£3,751GBP
- Report
- March 2026
- 150 Pages
Germany
From €4374EUR$4,850USD£3,751GBP
- Report
- March 2026
- 150 Pages
Germany
From €4374EUR$4,850USD£3,751GBP
- Report
- March 2026
- 194 Pages
Germany
From €4374EUR$4,850USD£3,751GBP

Biomedicine is a branch of biotechnology that focuses on the development of medical treatments and products. It involves the use of living organisms, such as bacteria, viruses, and cells, to create treatments and products that can be used to diagnose, prevent, and treat diseases. Biomedicine also includes the development of medical devices, such as prosthetics, and the use of genetic engineering to create new treatments.
Biomedicine is a rapidly growing field, with many companies investing in research and development. Companies in the biomedicine market are focused on developing treatments and products for a variety of diseases, including cancer, diabetes, and cardiovascular diseases. They are also working to develop treatments for rare diseases and to improve existing treatments.
Some of the companies in the biomedicine market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Celgene, Gilead Sciences, Johnson & Johnson, Merck, Novartis, Pfizer, and Roche. Show Less Read more